Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-05-01T07:44:01.653Z Has data issue: false hasContentIssue false

16 - Ancillary tests

Published online by Cambridge University Press:  05 September 2014

Grace C. H. Yang
Affiliation:
Weill Medical College of Cornell University
Get access

Summary

Chemistry

Thyroglobulin assay in neck cyst is useful to confirm metastatic papillary thyroid carcinoma, when the cyst fluid is too thin to be recognized as thin colloid on Diff-Quik stain (Fig. 14.8). In addition, parathyroid hormone assay is essential in the initial diagnosis of parathyroid cyst (Fig. 13.23).

Immunohistochemistry

Immunostains work best on cell block, but also work very well on Ultrafast Papanicolaou-stained smears due to the presence of formalin in the alcohol-based fixative and the clean background from hemolysis of aspirated blood., The majority of immunostains illustrated throughout this book were done directly on Ultrafast Papanicolaou-stained smears without destaining. Unlike deep-seated FNAs in the hospital setting, immunostains in this series were performed on direct smears primarily because the sample obtained from 27-gauge needles without suction was adequate for making smears but insufficient for making cell blocks.

A positive calcitonin immunostain is essential, prior to total thyroidectomy for medullary carcinoma. If calcitonin immunostain is negative or equivocal, the author will downgrade the diagnosis and report “atypical, cannot exclude” or “suspicious for” medullary carcinoma, so that frozen section will be performed. TTF-1 immunostain is useful in thyroid origin of poorly differentiated carcinoma (Fig. 10.5) and PAX8 useful in thyroid origin of anaplastic carcinoma (Figs. 11.5 and 11.10).

CK19 immunostain is useful to confirm follicular variant of papillary carcinoma. The author encountered an extremely scanty cellular FNA from a calcified nodule. CK19 positivity on the approximately 20 grape-like clear nuclei added immunohistochemical evidence of follicular variant of papillary carcinoma (Fig. 16.1).

Other useful immunomarkers for papillary carcinoma include HBME-1 and galactin-3 (Fig. 16.2). In a study to evaluate the usefulness of four immunomarkers in the histological diagnosis of encapsulated follicular tumors with questionable nuclear features of papillary carcinoma, Scognamiglio et al. reported that all four markers showed higher expression in encapsulated follicular variant of papillary carcinoma than follicular adenoma. HBME-1 was the most specific (96%), whereas CK19 was the most sensitive (96%). 100% specificity was seen with coexpression of HBME-1 and CK19. Galactin-3 and CITED1, less useful individually, were helpful in selective cases.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Zu, Y, Gangi, MD, Yang, GCH.Ultrafast Papanicolaou stain and cell-transfer technique enhance cytologic diagnosis of Hodgkin lymphoma. Diagn Cytopathol 2002; 27: 308–11.CrossRefGoogle ScholarPubMed
Shidham, VB, Chang, CC, Rao, RN, Komorowski, R, Chivukula, M.Immunostaining of cytology smears: a comparative study to identify the most suitable method of smear preparation and fixation with reference to commonly used immunomarkers. Diagn Cytopathol 2003; 29: 217–21.CrossRefGoogle ScholarPubMed
Sack, MT, Astengo-Osuna, C, Lin, BT, Battifora, H, LiVolsi, VA.HBME-1 immunostaining in thyroid fine-needle aspirations: A useful marker in the diagnosis of carcinoma. Mod Pathol 1997; 10: 668–74.Google Scholar
Xu, XC, el-Naggar, AK, Lotan, R.Differential expression of galectin-1 and galectin-3 in thyroid tumors: Potential diagnostic implications. Am J Pathol 1995; 147: 815–22.Google ScholarPubMed
Scognamiglio, T, Hyjek, E, Kao, J, Chen, YT.Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol 2006; 126: 700–8.CrossRefGoogle ScholarPubMed
Saggiorato, E, Aversa, S, Deandreis, D, et al. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas. J Endocrinol Invest 2004; 27: 311–17.CrossRefGoogle ScholarPubMed
Chiu, CG, Strugnell, SS, Griffith, OL, et al. Diagnostic utility of galectin-3 in thyroid cancer(Review). Am J Pathol 2010; 176: 2067–81.CrossRefGoogle Scholar
Cassol, CA.Asa, SL.Molecular pathology of thyroid cancer (Review). Diagn Histopathol 2011; 17: 124–39.CrossRefGoogle Scholar
Nikiforov, MN, Nikiforov, YE.Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009; 19: 1351–61.CrossRefGoogle Scholar
Xing, M, Tufano, RP, Tufaro, AP, et al. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 2004; 89: 2867–72.CrossRefGoogle ScholarPubMed
Ouyang, b, Knauf, JA, Smith, EP, et al. Inhibitors of RAF kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Clin Cancer Res 2006; 12: 1785–93.CrossRefGoogle ScholarPubMed
Zhu, Z, Gandhi, M, Nikiforova, MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma: An unusually high prevalence of RAS mutations. Am J Clin Pathol 2003; 120: 71–7.CrossRefGoogle ScholarPubMed
Basolo, F, Giannini, R, Monaco, C, et al. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall cell variant of papillary thyroid carcinoma. Am J Pathol 2002; 160: 247–54.CrossRefGoogle ScholarPubMed
Kroll, TG, Sarraf, P, Pecciarini, L, et al. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 2000; 289: 1357–60.CrossRefGoogle ScholarPubMed
Marques, AR, Espadinha, C, Catarino, AL, et al. Expression of PAX8–PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 2002; 87: 3947–52.Google ScholarPubMed
Cheung, L, Messina, M, Gill, A, et al. Detection of the PAX8–PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 2003; 88: 354–7.CrossRefGoogle ScholarPubMed
Barden, CB, Shister, KW, Zhu, BX, et al. Classification of follicular thyroid tumors by molecular signature: Results of gene profiling. Clin Cancer Res 2003; 9: 1792–800.Google ScholarPubMed
Hunt, JL, LiVolsi, VA, Baloch, ZW, et al. A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness. Hum Pathol 2003; 34: 375–80.CrossRefGoogle ScholarPubMed
Nikiforov, YE, Ohori, NP, Hodak, SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011; 96: 3390–7.CrossRefGoogle ScholarPubMed
Chen, YT, Kitabayashi, N, Zhou, XK, Fahey, TJ 3rd, Scognamiglio, T.MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 2008; 21: 1139–46.CrossRefGoogle ScholarPubMed
Keutgen, XM, Filicori, F, Crowley, MJ, et al. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res 2012; 18: 2032–8.CrossRefGoogle ScholarPubMed
Baloch, ZW, Alexander, EK, Gharib, H.Raab, SS.Overview of diagnostic terminology and reporting. In: Ali, SZ, Cibas, ES (eds.) The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes. New York: Springer, 2010.Google Scholar
Alexander, EK, Kennedy, GC, Baloch, ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 2012; 367: 705–15.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Ancillary tests
  • Grace C. H. Yang
  • Book: Thyroid Fine Needle Aspiration
  • Online publication: 05 September 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139135504.017
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Ancillary tests
  • Grace C. H. Yang
  • Book: Thyroid Fine Needle Aspiration
  • Online publication: 05 September 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139135504.017
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Ancillary tests
  • Grace C. H. Yang
  • Book: Thyroid Fine Needle Aspiration
  • Online publication: 05 September 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139135504.017
Available formats
×